🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/03/2008 | 40,26 | 41,56 | 40,25 | 40,51 | +0,31% | 3,27% | 16.401.619 |
| 11/03/2008 | 39,39 | 40,44 | 39,22 | 40,38 | +2,57% | 3,10% | 17.351.002 |
| 10/03/2008 | 39,89 | 39,99 | 39,15 | 39,37 | -1,17% | 2,11% | 12.954.957 |
| 07/03/2008 | 40,13 | 41,03 | 39,62 | 39,84 | -1,51% | 3,52% | 16.117.402 |
| 06/03/2008 | 41,29 | 41,30 | 40,37 | 40,45 | -1,99% | 2,24% | 16.148.422 |
| 05/03/2008 | 41,76 | 41,87 | 40,76 | 41,27 | -1,17% | 2,65% | 18.069.930 |
| 04/03/2008 | 41,71 | 41,98 | 41,30 | 41,76 | -0,68% | 1,65% | 14.885.792 |
| 03/03/2008 | 42,64 | 42,64 | 41,84 | 42,04 | -0,54% | 1,88% | 12.245.775 |
| 29/02/2008 | 42,80 | 42,91 | 42,11 | 42,27 | -1,99% | 1,87% | 17.982.527 |
| 28/02/2008 | 43,34 | 43,50 | 42,78 | 43,13 | -0,53% | 1,67% | 10.876.354 |
| 27/02/2008 | 44,08 | 44,12 | 43,22 | 43,36 | -2,05% | 2,06% | 16.659.951 |
| 26/02/2008 | 44,42 | 44,74 | 44,06 | 44,27 | -0,85% | 1,55% | 10.225.860 |
| 25/02/2008 | 44,06 | 44,77 | 44,01 | 44,65 | +1,56% | 1,73% | 11.296.811 |
| 22/02/2008 | 44,11 | 44,35 | 43,28 | 43,96 | -0,13% | 2,42% | 13.047.286 |
| 21/02/2008 | 44,93 | 45,23 | 43,91 | 44,02 | -1,89% | 2,93% | 12.777.740 |
| 20/02/2008 | 44,68 | 44,90 | 44,06 | 44,87 | -0,11% | 1,88% | 14.091.827 |
| 19/02/2008 | 45,75 | 46,02 | 44,80 | 44,91 | -0,97% | 2,67% | 13.947.622 |
| 15/02/2008 | 44,85 | 45,70 | 44,60 | 45,35 | +1,34% | 2,45% | 16.393.130 |
| 14/02/2008 | 45,61 | 45,93 | 44,61 | 44,75 | -1,41% | 2,89% | 13.190.442 |
| 13/02/2008 | 44,76 | 45,73 | 44,76 | 45,39 | +2,23% | 2,17% | 20.315.585 |
| 12/02/2008 | 43,56 | 44,94 | 43,41 | 44,40 | +2,69% | 3,53% | 21.690.666 |
| 11/02/2008 | 42,51 | 43,37 | 42,18 | 43,23 | +1,75% | 2,81% | 12.429.909 |
| 08/02/2008 | 43,46 | 43,61 | 42,24 | 42,49 | -2,56% | 3,14% | 14.534.502 |
| 07/02/2008 | 43,54 | 44,53 | 42,99 | 43,61 | -0,02% | 3,55% | 21.594.459 |
| 06/02/2008 | 44,06 | 44,29 | 42,76 | 43,62 | -0,52% | 3,49% | 17.132.599 |
| 05/02/2008 | 45,15 | 45,17 | 43,76 | 43,85 | -3,20% | 3,13% | 20.064.903 |
| 04/02/2008 | 43,72 | 45,77 | 43,72 | 45,30 | +3,24% | 4,69% | 17.087.535 |
| 01/02/2008 | 44,08 | 44,33 | 43,00 | 43,87 | -0,26% | 3,03% | 20.235.308 |
| 31/01/2008 | 44,21 | 44,48 | 43,01 | 43,99 | -0,11% | 3,32% | 26.332.048 |
| 30/01/2008 | 43,61 | 44,76 | 43,24 | 44,04 | -3,87% | 3,48% | 34.979.934 |